Technical Analysis for STLT - Spotlight Innovation Inc

Grade Last Price % Change Price Change
grade D 0.0078 0.00% 0.0000
STLT closed unchanged on Thursday, September 12, 2019, on 1 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Down Down
See historical STLT trend table...

Date Alert Name Type % Chg
MACD Bearish Centerline Cross Bearish 0.00%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
Narrow Range Bar Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Oversold Stochastic Weakness 0.00%
Narrow Range Bar Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Oversold Stochastic Weakness 0.00%
MACD Bearish Signal Line Cross Bearish 0.00%
Narrow Range Bar Range Contraction 0.00%

Older signals for STLT ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Spotlight Innovation Inc., formerly American Exploration Corporation, is a bioscience company. The Company is focused on acquiring the rights, through acquisition, license or otherwise, to various technologies. The Company is engaged in identifying and targeting technology candidates, including cancer drugs and treatment therapies for various disease states; drug and related treatment therapies for various infectious diseases, and other technology candidates. The Company focuses on diseases that are rare, which are known as orphan diseases, or new or common but underserved, such as feline chronic kidney disease. As of December 31, 2015, the Company had three subsidiaries: Celtic Biotech Iowa, Inc., CDT Veterinary Therapeutics, Inc. and Memcine Pharmaceuticals, Inc. Through its subsidiary, Celtic Biotech Iowa, Inc., it develops a range of drug candidates, such as Crotoxin, Cardiotoxin, VRCTC310 and Crotamine. Through its subsidiary, Memcine Pharmaceuticals, Inc., it offers Immunoplex.
Cancer Life Sciences Diseases Infectious Diseases Disease Iowa Spotlight Innovation Janssen Biotech Orphan Diseases Urbandale
Is STLT a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Recent News
Indicator Value
52 Week High 0.23
52 Week Low 0.002
Average Volume 7,157
200-Day Moving Average 0.0319
50-Day Moving Average 0.0112
20-Day Moving Average 0.0112
10-Day Moving Average 0.0147
Average True Range 0.0044
ADX 19.05
+DI 37.6645
-DI 52.6316
Chandelier Exit (Long, 3 ATRs ) 0.0208
Chandelier Exit (Short, 3 ATRs ) 0.0193
Upper Bollinger Band 0.0241
Lower Bollinger Band -0.0017
Percent B (%b) 0.37
BandWidth 230.357143
MACD Line 0.0
MACD Signal Line 0.0006
MACD Histogram -0.0007
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.0078
Resistance 3 (R3) 0.0078 0.0078 0.0078
Resistance 2 (R2) 0.0078 0.0078 0.0078 0.0078
Resistance 1 (R1) 0.0078 0.0078 0.0078 0.0078 0.0078
Pivot Point 0.0078 0.0078 0.0078 0.0078 0.0078
Support 1 (S1) 0.0078 0.0078 0.0078 0.0078 0.0078
Support 2 (S2) 0.0078 0.0078 0.0078 0.0078
Support 3 (S3) 0.0078 0.0078 0.0078
Support 4 (S4) 0.0078